We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.26B
AUM Growth
-$105M
Cap. Flow
+$387K
Cap. Flow %
0.01%
Top 10 Hldgs %
17.57%
Holding
140
New
2
Increased
92
Reduced
42
Closed
4

Top Buys

Rank Stock Value
1
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$17.8M
2
KBH icon
KB Home
KBH
+$10.3M
3
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
+$9.42M
4
JJSF icon
J&J Snack Foods
JJSF
+$9.25M
5
HURN icon
Huron Consulting
HURN
+$8.15M

Top Sells

Rank Stock Value
1
QTS
QTS REALTY TRUST, INC.
QTS
+$84.8M
2
CRL icon
Charles River Laboratories
CRL
+$29.5M
3
EVR icon
Evercore
EVR
+$13.2M
4
PFPT
Proofpoint, Inc.
PFPT
+$12.3M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.8M

Sector Composition

Rank Sector Weight
1 Industrials 20.15%
2 Healthcare 17.71%
3 Technology 17.37%
4 Financials 15.39%
5 Consumer Discretionary 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUBI icon
26
Customers Bancorp
CUBI
$2.66B
$46.1M 1.08%
1,072,042
+5,768
+0.5% +$225K
BDC icon
27
Belden
BDC
$4.85B
$45.8M 1.08%
786,577
-841
-0.1% -$45.1K
FLWS icon
28
1-800-Flowers.com
FLWS
$250M
$45.5M 1.07%
1,491,787
+73,895
+5% +$2.34M
AIN icon
29
Albany International
AIN
$2.11B
$45.5M 1.07%
591,451
+1,440
+0.2% +$116K
SBNY
30
DELISTED
Signature Bank
SBNY
$45.2M 1.06%
165,869
-320
-0.2% -$80.4K
KBR icon
31
KBR
KBR
$4.62B
$44.5M 1.05%
1,130,653
+60,065
+6% +$2.33M
HLF icon
32
Herbalife
HLF
$1.29B
$44.2M 1.04%
1,042,324
+102,271
+11% +$5.06M
KRA
33
DELISTED
Kraton Corporation
KRA
$44M 1.03%
963,577
-40,781
-4% -$1.62M
AZPN
34
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$43.5M 1.02%
354,357
+701
+0.2% +$86.1K
PBH icon
35
Prestige Consumer Healthcare
PBH
$2.38B
$43.1M 1.01%
768,011
+278
+0% +$15.3K
FCN icon
36
FTI Consulting
FCN
$4.4B
$42.2M 0.99%
313,371
+5,998
+2% +$833K
STAG icon
37
STAG Industrial
STAG
$7.38B
$41.7M 0.98%
1,062,125
+9,121
+0.9% +$373K
BKU icon
38
Bankunited
BKU
$3.37B
$40.3M 0.94%
962,925
+61,569
+7% +$2.52M
MATW icon
39
Matthews International
MATW
$866M
$40.2M 0.94%
1,159,072
+57,861
+5% +$1.99M
QDEL icon
40
QuidelOrtho
QDEL
$1.14B
$39.3M 0.92%
278,518
+6,616
+2% +$889K
HQY icon
41
HealthEquity
HQY
$8.41B
$39M 0.92%
602,252
+93,146
+18% +$6.47M
HBAN icon
42
Huntington Bancshares
HBAN
$34.4B
$37.8M 0.89%
2,446,785
-30,418
-1% -$448K
WSC icon
43
WillScot Mobile Mini Holdings
WSC
$4.39B
$37M 0.87%
1,166,404
-902
-0.1% -$26.1K
PACW
44
DELISTED
PacWest Bancorp
PACW
$36.9M 0.87%
815,086
-4,625
-0.6% -$192K
BOX icon
45
Box
BOX
$4.37B
$36.2M 0.85%
1,529,582
+17,156
+1% +$421K
CTLT
46
DELISTED
CATALENT, INC.
CTLT
$36M 0.84%
270,610
+156
+0.1% +$19.5K
WWE
47
DELISTED
World Wrestling Entertainment
WWE
$35.4M 0.83%
629,116
+82,438
+15% +$4.29M
SUPN icon
48
Supernus Pharmaceuticals
SUPN
$2.59B
$35.2M 0.82%
1,318,109
+256,456
+24% +$6.88M
BWIN
49
Baldwin Insurance Group
BWIN
$2.69B
$34.7M 0.81%
1,043,251
+56,454
+6% +$1.77M
CHRS icon
50
Coherus Oncology
CHRS
$217M
$34.6M 0.81%
2,155,221
+164,778
+8% +$2.42M
1
2
3 4 5

Similar funds

SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

Aristotle Capital Boston's Q3 2021 Portfolio in Review

As of Q3 2021, Aristotle Capital Boston held 140 positions worth $4.26B, down 2.4% from $4.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.3%. Aristotle Capital Boston opened 2 new positions and exited 4, leaving the 140-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Aristotle Capital Boston's largest Q3 2021 buy was J&J Snack Foods: 56,803 shares worth $8.68M.
  • Aristotle Capital Boston added most to PetIQ, Inc. Class A Common Stock in Q3 2021, an estimated $17.8M increase.
  • Aristotle Capital Boston's biggest Q3 2021 reduction was Charles River Laboratories, cutting an estimated $29.5M.
  • Aristotle Capital Boston fully exited QTS REALTY TRUST, INC. in Q3 2021, selling an estimated $84.8M.
  • Aristotle Capital Boston's ten largest holdings make up 18% of its $4.26B portfolio in Q3 2021.
  • Aristotle Capital Boston opened 2 new positions and closed 4 in Q3 2021.
  • Aristotle Capital Boston's portfolio value fell 2.4% quarter-over-quarter to $4.26B.

Based on Aristotle Capital Boston's 13F filing for Q3 2021, filed 15 Nov 2021.